Pearlie P. Chong

The University of Texas Southwestern Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients”.

920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients

American Journal of Transplantation(2023)10.1016/j.ajt.2026.04.010

N/A

0.208DataRank · unranked

3 citations

Michelle Callegari, Diana F. Florescu, M. Hong Nguyen, Daniel Kaul, Robin K. Avery +14 more

Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study

Transplant Infectious Disease(2024)10.1111/tid.14270

N/A

0DataRank · unranked

6 citations

Lara Danziger‐Isakov, Anne Rose, Daniel Kaul, Kelly Shaffer, Pearlie P. Chong +12 more